Liminatus Pharma, Inc. Warrants — Institutional Ownership
Which tracked institutions hold LIMNW, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
6
Funds holding
$13159
Total value held
Buying
4 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Goldman Sachs Group Inc | $4440 | 40220 | +40220 | NEW BUY |
| 2 | Stonex Group Inc. | $3934 | 26058 | +26058 | NEW BUY |
| 3 | Ubs Group Ag | $2178 | 21237 | +21237 | NEW BUY |
| 4 | State Street Corp | $2098 | 19000 | — | Held |
| 5 | Barclays Plc | $474 | 4290 | +4290 | NEW BUY |
| 6 | Blackrock, Inc. | $35 | 313 | -12941 | -97.64% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.